Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Development of a fluorescence immunochromatographic assay for the detection of zeta globin in the blood of (--(SEA)) α-thalassemia carriers.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Wen L;Wen L; Zhu P; Liu Y; Pan Q; Qu Y; Xu X; Li X; Fu N
- Source:
Blood cells, molecules & diseases [Blood Cells Mol Dis] 2012 Oct 15-Dec 15; Vol. 49 (3-4), pp. 128-32. Date of Electronic Publication: 2012 Jun 05.
- Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
- Language:
English
- Additional Information
- Source:
Publisher: Academic Press Country of Publication: United States NLM ID: 9509932 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0961 (Electronic) Linking ISSN: 10799796 NLM ISO Abbreviation: Blood Cells Mol Dis Subsets: MEDLINE
- Publication Information:
Publication: <1996-> : Orlando, FL : Academic Press
Original Publication: La Jolla, Calif. : Blood Cells Foundation, 1995-
- Subject Terms:
- Abstract:
Southeast Asian deletion (--(SEA)) α-thalassemia is an inherited monogenic disorder of human hemoglobin, and embryonic globin ζ (hemoglobin ζ, zeta globin chain or Hb zeta chain) has been shown to be a marker that can be used for the identification of carriers of the (--(SEA)) α-thalassemia deletion. In this work, a fluorescence immunochromatographic assay (FL-ICA) was established to detect the zeta globin chain in the hemolysates of carriers of the (--(SEA)) α-thalassemia deletion. This assay can be completed within 10min using a simple UV detector and does not suffer from interference from the red background color of the hemolysate. A total of 314 blood samples were tested by FL-ICA and ELISA. The results of these assays were confirmed by PCR, the standard technique for genetic disease testing. The sensitivity and specificity of this novel FL-ICA were 100% and 98.0%, respectively; the corresponding values for the ELISA performed simultaneously were 100% and 99.2%, respectively. In conclusion, a new FL-ICA-a simple, fast, convenient, low-cost method-was developed that may be useful in both high-throughput screening and individual detection of the (--(SEA)) α-thalassemia deletion in carriers. Additionally, this qualitative FL-ICA may enlighten the development of a new systems for analysis of other target molecules using whole-blood samples.
(Copyright © 2012 Elsevier Inc. All rights reserved.)
- Accession Number:
0 (Antibodies, Monoclonal)
0 (zeta-Globins)
- Publication Date:
Date Created: 20120609 Date Completed: 20130308 Latest Revision: 20220409
- Publication Date:
20240829
- Accession Number:
10.1016/j.bcmd.2012.05.011
- Accession Number:
22677106
No Comments.